Breaking News Instant updates and real-time market news.

ILMN

Illumina

$363.55

-9.15 (-2.46%)

16:41
07/11/19
07/11
16:41
07/11/19
16:41

Illumina down 15% to $309.47 after lowering FY19 revenue outlook

The company also reported preliminary Q2 revenue of $835M, below consensus of $888.18M.

  • 06

    Aug

  • 08

    Aug

  • 03

    Sep

ILMN Illumina
$363.55

-9.15 (-2.46%)

06/10/19
ADAM
06/10/19
NO CHANGE
Target $30
ADAM
Buy
Illumina price target raised to $360 from $350 at Canaccord
Canaccord analyst Mark Massaro raised his price target on Illumina to $360 from $350 following meeting with management. The analyst said he sees a multi-year path to growth ahead in research and clinical sequencing. He acknowledged there are near-term risks but said he is confident that demand for high-margin sequencing consumables is intact and that the company's commitment to R&D spending coupled with its best in class people, will enable it to maintain its leadership position for years. Massaro reiterated his Buy rating on Illumina shares.
06/13/19
CANT
06/13/19
NO CHANGE
Target $8
CANT
Neutral
Cantor sees Pacific Biosciences deal closing despite U.K. probe risk
Cantor Fitzgerald analyst Jordan Abrams points out that the deadline for the U.K.'s Competition and Markets Authority to determine whether or not to move to a Phase 2 investigation on Illumina's (ILMN) proposed buyout of Pacific Biosciences (PACB) is June 18. The analyst's due diligence suggests the acquisition is at risk to move to a Phase 2 investigation, but his view is that the deal will ultimately close. Nonetheless, he expects additional pressure on Pacific Biosciences shares if CMA moves forward with a Phase 2 investigation. Pacific shares last closed at a 19% discount $8 acquisition price, and the deal is still expected to close mid-2019, Abrams tells investors in a research note. He keeps a Neutral rating on Pacific Biosciences.
06/20/19
CANT
06/20/19
NO CHANGE
Target $8
CANT
Neutral
Cantor still expects Pacific Biosciences deal to be approved in Europe
Cantor Fitzgerald analyst Jordan Abrams still expects Illumina's (ILMN) acquisition of Pacific Biosciences (PACB) to be approved in Europe after the Competition and Markets Authority referred the deal to a Phase 2 investigation. The CMA's initial due diligence on anti-competitive concerns was justified, but a better understanding of Pacific Biosciences technology will show that long-read in its current form is a complement, rather than a substitute, to short-read, Abrams tells investors in a research note after hosting an investor call with a competition specialist. He keeps a Neutral rating on Pacific shares with an $8 price target.
07/09/19
PIPR
07/09/19
NO CHANGE
PIPR
Overweight
Illumina checks show strong interest in NovaSeq, says Piper Jaffray
Piper Jaffray analyst William Quirk says his instrument checks suggest little upside from Novaseq systems in Illumina's Q2. However, NovaSeq interest appears to be strong when analyzing search traffic, Quirk tells investors in a research note. The analyst believes consumables growth will drive the company's Q2 results, "powered by large scale projects and oncology." He maintains an Overweight rating on Illumina with a $387 price target.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,992.41

-17.59 (-0.88%)

08:54
07/18/19
07/18
08:54
07/18/19
08:54
Periodicals
Amazon's Go outlets in Chicago falling short of expectations, Bloomberg reports »

Amazon's Go…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

WP

Worldpay

$132.28

1.07 (0.82%)

08:52
07/18/19
07/18
08:52
07/18/19
08:52
Initiation
Worldpay initiated  »

Worldpay assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONEXF

Onex

$0.00

(0.00%)

08:52
07/18/19
07/18
08:52
07/18/19
08:52
Hot Stocks
Onex to sell Jack's Family Restaurants, terms not disclosed »

Onex Corporation and its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$39.03

-0.87 (-2.18%)

, FB

Facebook

$201.97

-1.9 (-0.93%)

08:51
07/18/19
07/18
08:51
07/18/19
08:51
Recommendations
eBay, Facebook analyst commentary  »

eBay price target raised…

EBAY

eBay

$39.03

-0.87 (-2.18%)

FB

Facebook

$201.97

-1.9 (-0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

WEX

Wex

$218.50

0.11 (0.05%)

08:51
07/18/19
07/18
08:51
07/18/19
08:51
Initiation
Wex initiated  »

Wex assumed with a Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOK

MyoKardia

$49.90

-0.21 (-0.42%)

08:50
07/18/19
07/18
08:50
07/18/19
08:50
Hot Stocks
MyoKardia expects cash, cash equivalents to fund operations into 2H21 »

MyoKardia's cash…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

V

Visa

$179.16

-0.14 (-0.08%)

08:50
07/18/19
07/18
08:50
07/18/19
08:50
Initiation
Visa initiated  »

Visa assumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

TSS

TSYS

$133.04

0.06 (0.05%)

08:50
07/18/19
07/18
08:50
07/18/19
08:50
Initiation
TSYS initiated  »

TSYS assumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIR

Circor

$37.12

-1.22 (-3.18%)

08:50
07/18/19
07/18
08:50
07/18/19
08:50
Upgrade
Circor rating change  »

Circor upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

MYOK

MyoKardia

$49.90

-0.21 (-0.42%)

, SNY

Sanofi

$41.57

-0.25 (-0.60%)

08:49
07/18/19
07/18
08:49
07/18/19
08:49
Hot Stocks
MyoKardia re-acquires U.S. royalty rights to HCM programs from Sanofi »

MyoKardia (MYOK)…

MYOK

MyoKardia

$49.90

-0.21 (-0.42%)

SNY

Sanofi

$41.57

-0.25 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

  • 09

    Sep

  • 16

    Sep

  • 23

    Sep

  • 02

    Oct

SQ

Square

$80.81

0.23 (0.29%)

08:49
07/18/19
07/18
08:49
07/18/19
08:49
Initiation
Square initiated  »

Square assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

TMDI

Titan Medical

$2.19

-0.025 (-1.13%)

08:49
07/18/19
07/18
08:49
07/18/19
08:49
Hot Stocks
Titan Medical completes GLP procedures with single-port robotic surgery system »

Titan Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$118.80

-0.88 (-0.74%)

08:49
07/18/19
07/18
08:49
07/18/19
08:49
Initiation
PayPal initiated  »

PayPal assumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

MYOK

MyoKardia

$49.90

-0.21 (-0.42%)

08:48
07/18/19
07/18
08:48
07/18/19
08:48
Hot Stocks
MyoKardia expects to report topline data from EXPLORER-HCM trial in 2Q20 »

MyoKardia announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

MA

MasterCard

$275.34

-1.1 (-0.40%)

08:48
07/18/19
07/18
08:48
07/18/19
08:48
Initiation
MasterCard initiated  »

MasterCard assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

GDOT

Green Dot

$47.85

-0.525 (-1.09%)

08:47
07/18/19
07/18
08:47
07/18/19
08:47
Initiation
Green Dot initiated  »

Green Dot assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPN

Global Payments

$165.06

0.215 (0.13%)

08:47
07/18/19
07/18
08:47
07/18/19
08:47
Initiation
Global Payments initiated  »

Global Payments assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 13

    Nov

FLT

FleetCor

$289.72

-1.21 (-0.42%)

08:46
07/18/19
07/18
08:46
07/18/19
08:46
Initiation
FleetCor initiated  »

FleetCor assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPC

Genuine Parts

$102.27

-3.07 (-2.91%)

08:46
07/18/19
07/18
08:46
07/18/19
08:46
Earnings
Genuine Parts updates FY19 revenue growth view to 4.5%-5.5%, consensus $19.55B »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

SPNE

SeaSpine

$12.73

(0.00%)

08:45
07/18/19
07/18
08:45
07/18/19
08:45
Hot Stocks
SeaSpine announces release of OsteoStrand, OsteoStrand Plus DBM Fibers »

SeaSpine Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$6.56

0.26 (4.13%)

, SAP

SAP

$134.22

-0.9 (-0.67%)

08:45
07/18/19
07/18
08:45
07/18/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

APHA

Aphria

$6.56

0.26 (4.13%)

SAP

SAP

$134.22

-0.9 (-0.67%)

OSTK

Overstock.com

$18.90

1.13 (6.36%)

SIL

APEX Silver Mines

$28.29

1.23 (4.55%)

FCEL

FuelCell

$0.31

-0.014 (-4.38%)

TZA

Small Cap Bear 3x

$46.85

1.05 (2.29%)

TLT

iShares 20+ Year Treasury Bond Fund

$131.99

1.42 (1.09%)

SQQQ

ProShares UltraPro Short QQQ

$32.21

0.42 (1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 01

    Aug

  • 01

    Aug

08:45
07/18/19
07/18
08:45
07/18/19
08:45
General news
U.S. initial jobless claims rose 8k to 216k in the week ended July 13 »

U.S. initial jobless…

MS

Morgan Stanley

$43.78

-0.63 (-1.42%)

08:44
07/18/19
07/18
08:44
07/18/19
08:44
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley »

Morgan Stanley CFO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 11

    Sep

MS

Morgan Stanley

$43.78

-0.63 (-1.42%)

08:44
07/18/19
07/18
08:44
07/18/19
08:44
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley »

Morgan Stanley CFO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 11

    Sep

MS

Morgan Stanley

$43.78

-0.63 (-1.42%)

08:43
07/18/19
07/18
08:43
07/18/19
08:43
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley »

Morgan Stanley CFO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 11

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.